Pernod Ricard Fights Delhi Liquor Ban Amid India Regulatory Heat

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Pernod Ricard Fights Delhi Liquor Ban Amid India Regulatory Heat
Overview

Pernod Ricard is battling Indian authorities over its Delhi liquor license, which was rejected for the fourth time in February 2026. The company states its business has been "hopelessly fettered" for three years, leading to a new Delhi High Court challenge. The dispute, involving allegations of collusion with retailers in 2021 and an ongoing antitrust investigation, puts the French spirits giant under significant regulatory pressure in India, its key market by volume.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Pernod Ricard is locked in a difficult legal battle over its liquor license in Delhi, a situation that highlights significant regulatory challenges in India. The prohibition in the capital restricts access to its premium brands like Chivas Regal and Absolut Vodka for millions and signals wider risks for foreign companies navigating India's complex regulatory environment. This comes as competition and regulatory attention increase across India's $65 billion alcohol market.

The immediate issue stems from Delhi authorities rejecting Pernod Ricard's liquor license application for the fourth time in February 2026, following earlier denials since 2023. This has prompted the company to launch a new legal challenge. Pernod Ricard states the ban has "hopelessly fettered" its business in Delhi for three years. This market typically accounted for about 5% of its Indian sales, which totaled $2.86 billion for the year ending March 2025. As of May 11, 2026, Pernod Ricard's stock (RI.PA) traded around €61.50, with a market capitalization of approximately €15.45 billion. The stock has shown volatility, with a year-to-date return of -10.01% and a 52-week low of €58.60. The company maintains it should be permitted to operate in Delhi and is pursuing legal avenues. The Delhi government, however, is actively opposing the license, citing public interest and potential risks to the regulatory system, according to a court filing on April 30th.

Adding to the pressure, Pernod Ricard faces investigations into alleged business practices. India's financial crime agency has accused the company of colluding with Delhi retailers in 2021 to boost its market share, reportedly by ensuring 35% of their stock consisted of Pernod products. Furthermore, India's antitrust regulator launched a new investigation into similar practices last week. This dual scrutiny from financial crime and antitrust bodies creates significant uncertainty for the company.

These challenges occur within a dynamic Indian market. Competitors like Diageo India and Suntory are actively pursuing growth, with India's alcohol market expected to expand substantially. Diageo India's revenue reached ₹27,276 crore in FY25, closely followed by Pernod Ricard India's ₹27,445.80 crore, making them the top two players. Suntory aims for India to contribute over 10% of its global business, seeing significant potential, particularly in premium whisky. India's alcoholic beverage market is robust, with spirits dominating and a strong premiumization trend driving growth. However, companies face a highly regulated and fragmented market with substantial state-level variations in policies, taxation, and licensing. Overall, the Indian alcohol market is projected to reach $176.2 billion by 2034, led by spirits.

The ongoing regulatory issues pose a substantial risk for Pernod Ricard. The company's claim of being "hopelessly fettered" reflects the operational paralysis caused by the prolonged ban. Allegations of collusion, though denied, raise questions about compliance in high-growth emerging markets. Competitors have shown better recent performance: Diageo's sales rose 1.7% in the 12 months to June 2025, while Pernod Ricard saw a 3% decline in the same period. These legal and regulatory battles are not isolated; other foreign firms are challenging Indian tax policies, citing discrimination against imported brands and preferential treatment for local producers, suggesting a trend of protectionist measures that could hinder foreign investment and market access. Pernod Ricard's forward P/E ratio was about 10.94 on May 11, 2026, and its TTM P/E was 11.61 on May 8, 2026. These figures are below its 10-year median and industry averages, possibly reflecting market concerns over these regulatory risks. Recent analysis suggests Pernod Ricard could be a "value trap," trading significantly below its estimated fair value. The company also faces increasing competition from domestic players and a trend of premiumization, which can lead to price wars, as seen with Diageo's recent results.

Looking ahead, analysts generally maintain a positive outlook, with an average 12-month price target of €87.03, suggesting over 41% upside potential. However, the current regulatory entanglements in India, particularly the Delhi license dispute and antitrust investigation, create significant near-term uncertainty. Pernod Ricard's ability to navigate these complex legal and regulatory environments will be crucial for its growth ambitions in India, its largest market by volume. The outcome of the Delhi case and antitrust probe could set a precedent for foreign spirits companies operating in India.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.